AMED (Japan Agency for Medical R&D) logo
Program

Drug Discovery Support Network (DDSN)

Provides cutting-edge screening and optimization technologies across drug modalities through three research organizations.

AMED (Japan Agency for Medical R&D)JapanOther Transaction (OT)

The Drug Discovery Support Network (DDSN) pulls together three public research organizations — RIKEN, the National Institute of Biomedical Innovation, Health and Nutrition (NIBIOHN), and the National Institute of Advanced Industrial Science (AIST) — to support the iD3 Booster program. Established in 2013, the network provides cutting-edge technologies for high-throughput screening (HTS) and lead o…

Biotech
Max award-
Realistic median-
Success rate-
Decision time-

No upcoming rounds verified. Cadence: Rolling.